Expansion of the business and R&D platform through the acquisition of Terumo's nutritional food and related product assets
First written in FY2023-Q2. 2 of 4 entries say "Advanced", first in FY2024-Q1. Latest entry: FY2024.
The whole theme swung hardest in 2024: 1 of 7 companies on the "Worse" side.
4 other companies' latest entry also says "Advanced".
- FY2024AdvancedAnnual report
「The nutritional food and related product sales business acquired from テルモ㈱ also performed steadily during the previous consolidated fiscal year and contributed to full-year results.」
The nutritional food and related product sales business acquired from テルモ progressed from contributing for part of the period after the acquisition to contributing to full-year results. - FY2024-Q1AdvancedAnnual report
「Increased orders in the Bio Business and higher profit from sales of nutritional foods and related products acquired from テルモ in the previous consolidated fiscal year also contributed to business performance.」
Sales following the acquisition of nutritional foods and related products from テルモ appeared in the results as a driver of earnings growth. - FY2023-Q3AchievedAnnual report
「As announced on 7 September 2022, consolidated subsidiaries 三井製糖㈱ (now ＤＭ三井製糖㈱) and ニュートリー㈱ entered into an agreement with テルモ㈱ to acquire assets related to its nutritional foods and related products. The acquisition was completed during the third quarter of the current fiscal year. As part of the growth of the Life Energy business and the consolidation and strengthening of the Group’s R&D capabilities set out in the medium-term management plan, the transaction will enhance the Group’s product lineup and services and strengthen its ability to respond to diversifying customer needs. The Group will also further expand into areas such as home healthcare and pre-disease care by leveraging its R&D capabilities in functional materials, thereby driving further growth in the Life Energy business.」
The acquisition of テルモ’s nutritional food and related product assets was completed during the third quarter, and the company entered the phase of expanding its products and services and developing its home healthcare and pre-disease care businesses. - FY2023-Q2First statedAnnual report
「As announced on 7 September, consolidated subsidiaries 三井製糖㈱ (now ＤＭ三井製糖㈱) and ニュートリー㈱ entered into an agreement with テルモ㈱ to acquire assets related to its nutritional foods and related products. As part of the growth of the Life Energy business and the consolidation and strengthening of the Group’s R&D capabilities set out in the medium-term management plan, the transaction will enhance the Group’s product lineup and services and strengthen its ability to respond to diversifying customer needs. The Group will also further expand into areas such as home healthcare and pre-disease care by leveraging its R&D capabilities in functional materials, thereby driving further growth in the Life Energy business.」
The company entered into an agreement to acquire テルモ㈱’s assets related to nutritional foods and related products. It positioned the transaction as part of the growth of the Life Energy business and the consolidation and strengthening of R&D capabilities under its medium-term management plan, and set out plans to enhance its products and services and expand into home healthcare and pre-disease care.